Scarica l'app Stockscreener
2.79
2.45%
-0.07
Dopo l'orario di chiusura:
2.79
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ACHV Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$2.86
Aprire:
$2.79
Volume 24 ore:
1.48M
Relative Volume:
1.25
Capitalizzazione di mercato:
$142.58M
Reddito:
-
Utile/perdita netta:
$-32.94M
Rapporto P/E:
-2.5135
EPS:
-1.11
Flusso di cassa netto:
$-24.95M
1 W Prestazione:
-11.71%
1M Prestazione:
+8.14%
6M Prestazione:
-4.12%
1 anno Prestazione:
-34.35%
Intervallo 1D:
$2.74
$2.89
Intervallo di 1 settimana:
$2.74
$3.20
Portata 52W:
$1.84
$5.31
Achieve Life Sciences Inc Stock (ACHV) Company Profile
Nome
Achieve Life Sciences Inc
Settore
Industria
Telefono
425-686-1500
Indirizzo
22722 29TH DR. SE, SEATTLE, BC
Confronta ACHV con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ACHV
Achieve Life Sciences Inc
|
2.79 | 149.23M | 0 | -32.94M | -24.95M | -1.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Achieve Life Sciences Inc Stock (ACHV) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-21 | Iniziato | H.C. Wainwright | Buy |
| 2024-11-14 | Iniziato | Rodman & Renshaw | Buy |
| 2024-09-27 | Iniziato | Raymond James | Strong Buy |
| 2023-05-10 | Reiterato | Maxim Group | Buy |
| 2021-06-23 | Iniziato | Oppenheimer | Outperform |
Achieve Life Sciences Inc Borsa (ACHV) Ultime notizie
Volume spikes in Achieve Life Sciences Inc. stock – what they meanMarket Activity Recap & AI Optimized Trade Strategies - Newser
Achieve Life Sciences Announces FDA Acceptance of Cytisinicline New Drug Application for Treatment of Nicotine Dependence for Smoking Cessation - MarketScreener
FDA accepts Achieve Life Sciences’ NDA for smoking cessation drug - Investing.com
Achieve Life Sciences' nicotine dependence treatment under FDA review - Seeking Alpha
Achieve Life Sciences Says FDA Accepts Marketing Application for Smoking Cessation Drug - MarketScreener
First New Smoking Cessation Drug in Two Decades: FDA to Review Achieve's Cytisinicline Treatment - Stock Titan
Nantahala Capital Management LLC Has $2.40 Million Holdings in Achieve Life Sciences, Inc. $ACHV - MarketBeat
Can trapped investors hope for a rebound in Achieve Life Sciences Inc.Weekly Trend Summary & Target Return Focused Picks - Newser
Real time breakdown of Achieve Life Sciences Inc. stock performance2025 Risk Factors & Consistent Growth Equity Picks - Newser
How institutional ownership impacts Achieve Life Sciences Inc. stockPortfolio Performance Summary & Fast Moving Stock Trade Plans - Newser
Should you avoid Achieve Life Sciences Inc. stock right nowJuly 2025 Macro Moves & Scalable Portfolio Growth Methods - khodrobank.com
Smart tools for monitoring Achieve Life Sciences Inc.’s price actionWeekly Investment Report & Stock Portfolio Risk Management - Newser
Published on: 2025-09-03 03:38:25 - Newser
Measuring Achieve Life Sciences Inc.’s beta against major indicesJuly 2025 Snapshot & Daily Risk Controlled Trade Plans - Newser
Order flow analysis tools used on Achieve Life Sciences Inc.2025 Top Gainers & Low Risk Entry Point Guides - Newser
Published on: 2025-09-03 00:44:50 - Newser
Can Achieve Life Sciences Inc. outperform in the next rallyJuly 2025 Big Picture & Expert Verified Stock Movement Alerts - khodrobank.com
Technical analysis overview for Achieve Life Sciences Inc. stockIPO Watch & Free Weekly Chart Analysis and Trade Guides - Newser
Achieve Life Sciences shares rise 2.05% after-hours as CEO Rick Stewart participates in upcoming conferences. - AInvest
Will Achieve Life Sciences Inc. see short term momentum2025 Major Catalysts & Target Return Focused Picks - Newser
Is Achieve Life Sciences Inc. benefiting from interest rate changesWeekly Profit Recap & Expert Curated Trade Setups - خودرو بانک
News impact scoring models applied to Achieve Life Sciences Inc.July 2025 Reactions & High Yield Stock Recommendations - Newser
Using portfolio simulators with Achieve Life Sciences Inc. includedJuly 2025 Market Mood & Weekly Breakout Stock Alerts - Newser
Is Achieve Life Sciences Inc. a cyclical or defensive stockTake Profit & Real-Time Buy Signal Notifications - khodrobank.com
Chart based analysis of Achieve Life Sciences Inc. trends2025 Dividend Review & Fast Entry Momentum Alerts - Newser
Achieve Life Sciences Announces Participation at Upcoming Investor Conferences - GlobeNewswire
Achieve Life Sciences CEO to Present at Two Upcoming Conferences. - AInvest
Smoking Cessation Drug Developer Achieve Life Sciences Featured at Two Major Investment Conferences - Stock Titan
Why Achieve Life Sciences Inc. stock attracts strong analyst attentionMarket Risk Summary & Daily Market Momentum Tracking - Newser
Comparing Achieve Life Sciences Inc. in custom built stock radars2025 Growth vs Value & Weekly Chart Analysis and Trade Guides - Newser
What makes Achieve Life Sciences Inc. stock attractive to long term investorsTrade Risk Report & Risk Adjusted Buy and Sell Alerts - Newser
Using flow based indicators on Achieve Life Sciences Inc.2025 Market Outlook & Low Risk Profit Maximizing Plans - Newser
Is Achieve Life Sciences Inc. in accumulation or distribution phaseJuly 2025 Analyst Calls & Fast Gain Swing Alerts - khodrobank.com
Does Achieve Life Sciences Inc. meet Warren Buffett’s criteriaJuly 2025 Setups & Risk Controlled Swing Trade Alerts - khodrobank.com
Should you wait for a breakout in Achieve Life Sciences Inc.Weekly Market Outlook & Free Real-Time Volume Trigger Notifications - Newser
Can momentum traders help lift Achieve Life Sciences Inc.Weekly Trend Summary & Safe Capital Growth Plans - Newser
Is Achieve Life Sciences Inc. showing signs of accumulationGold Moves & Verified Momentum Stock Alerts - Newser
Evaluating Achieve Life Sciences Inc. with trendline analysis2025 Trade Ideas & Daily Profit Focused Stock Screening - Newser
Full technical analysis of Achieve Life Sciences Inc. stockWeekly Trend Recap & AI Powered Trade Plan Recommendations - Newser
What makes Achieve Life Sciences Inc. stock price move sharply getLinesFromResByArray error: size == 0 - 더경남뉴스
Achieve Life Sciences Inc. Added to Custom Quant Screener Today getLinesFromResByArray error: size == 0 - thegnnews.com
Published on: 2025-08-30 22:56:28 - Newser
Achieve Life Sciences Inc Azioni (ACHV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Achieve Life Sciences Inc Azioni (ACHV) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Stewart Richard Alistair | Chieve Executive Officer |
Mar 17 '25 |
Buy |
2.86 |
10,000 |
28,598 |
60,876 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):